≈ the.bay.news

Neuralink co-founder Max Hodak's Science Corp, which offers a retinal implant for age-related macular degeneration, raised $400M at a $3.5B valuation (Ike Swetlitz/Bloomberg)

0 comments

Sign in to join the discussion — your thebay.events account works here.

No comments yet.